Global Commercialization.
All Commercial Services. ONE Partner.
Meet Our Experts at Biotech Showcase
Join us at Informa’s Biotech Showcase™ during JPM week.
Fireside Chat: Biotech at a Crossroads: Rewiring Commercialization
San Francisco, CA | Monday, January 12, 2026 | 10:30am Pacific
Biotech is at an inflection point. Traditional commercialization must give way to innovative, capital-efficient models designed to accelerate market entry and maximize asset value. Join our expert panel for insights into emerging strategies, funding pathways, investor positioning, and lessons from recent launches.
Whether you’re a biotech founder preparing for Series B, an investor evaluating early-stage assets, or a commercial leader refining your launch strategy, this session offers actionable insights on risk management, value creation, and the milestones that matter most in today’s dynamic environment.
Featured Speakers:
- Greg Skalicky – President, EVERSANA
- Helen Sabzevari – CEO and President, Precigen
- Andy Udell – CCO, Actinigen Medical
Stop juggling disconnected vendors. With our ONE Partner model, you get every commercial service under one roof—streamlined, integrated, and designed to add value to your product and organization.
Meet our experts at the J.P. Morgan Healthcare Conference in San Francisco, January 12–15, 2026. Let’s explore smarter commercialization strategies for your assets. We make it simple to build value, whether you’re considering alternatives to selling, out-licensing, or launching internally. Join us for a conversation and discover your options.
We’re excited to connect with you, no matter where you are on your journey.
Schedule a meeting if you’re:
- An emerging biotech preparing for your first product launch
- A pharma executive managing an established portfolio
- An investor seeking predictability and growth opportunities
Driving the Next Era of Life Sciences
The life sciences sector has been long overdue for transformation. Fueled by increasing pressures on both established and emerging pharmaceutical companies, combined with investment market volatility, regional and regulatory complexities, and the need to improve both brand value and patient impact, we reinvented commercialization.
EVERSANA Is Redefining Commercialization
We deliver the industry’s only fully integrated commercial services platform, solving challenges across pricing, promotion, market access, reimbursement, adherence, and product delivery.
Why EVERSANA?
Powered by data and digital innovation, our future-ready infrastructure and proven expertise enable us to manage every aspect of your launch and commercialization strategy, or address specific program and patient needs with precision.
Explore Our Commercial Models
- EVERSANA COMPLETE Commercialization: A ready-to-deploy, high-performance commercialization and distribution engine. Mitigate risk and avoid building costly infrastructure.
- EVERSANA REIGNITE: Designed for large pharma portfolios. Maximize product value before loss of exclusivity and optimize revenue in the late stages of the product lifecycle.